Actively Recruiting
Comparing Two Stapled Antimesenteric Anastomosis Techniques to Reduce Crohns Disease Recurrence after Bowel Surgery
Led by Jinling Hospital, China · Updated on 2022-12-20
236
Participants Needed
1
Research Sites
260 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are comparing two types of stapled antimesenteric anastomosis techniques used after bowel resection in patients with Crohns disease to see which is better at reducing postoperative recurrence. Crohns disease can often return after surgery, and while the stapled anti-mesenteric functional end-to-end anastomosis Kono-S has been found safe, its benefit over the conventional stapled antimesenteric isoperistaltic side-to-side anastomosis is unknown. This randomized control trial aims to explore the difference in recurrence rates following these two surgical methods. Participants will be randomly assigned to receive either the stapled Kono-S anastomosis or the stapled antimesenteric isoperistaltic side-to-side anastomosis after their bowel resection. Both are surgical procedures performed during the operation to reconnect the bowel. The study will monitor the patients over time to compare the outcomes of these two anastomosis techniques. Throughout the study, researchers will assess the endoscopic recurrence rate of Crohns disease one year after surgery, which is the primary outcome measure. Secondary outcomes include clinical and surgical recurrence rates at one and five years post-surgery, as well as quality of life assessments using the inflammatory bowel disease questionnaire IBDQ and Short Form 12 surveys. The study is double-blinded and randomized, with participants aged 16 to 60 years, and involvement may last several years to capture these outcomes.
CONDITIONS
Brief Title
Comparison of Two Stapled Antimesenteric Anastomosis for CD: a Randomized Control Trial Study
Research Team
M
ming duan, M.D.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here